AcneFree Is Latest In Rash Of NAD Decisions Against University Medical
This article was originally published in The Tan Sheet
Executive SummaryUniversity Medical Pharmaceuticals continues to have trouble supporting its competitive marketing claims to the satisfaction of the National Advertising Division
You may also be interested in...
Okla. and Ala. limit PSE sales while Colo. and Hawaii consider NPLEx; Abbott, Biocon team on Indian nutrition R&D; Bunge leaves Solae stake to DuPont; Valeant buys AcneFree; more news In Brief.